×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

AMGEN'S COMMITMENT TO PATIENTS

At Amgen, our mission to serve patients is evident in our unwavering commitment to deliver breakthrough treatments for unmet medical needs. We believe that innovative medicines are the best hope to reduce both the human and financial burden that serious diseases, such as cancer and heart disease, place on people, their families and our society. Such medicines can play a major role in reducing rising healthcare costs worldwide. These costs are fueled, in part, by aging populations that are straining healthcare systems around the world. Amgen is committed to working with the entire healthcare community to ensure a fertile environment for innovation and to encourage an equitable healthcare system that enables patients to access the medicines they need.

Amgen’s commitment means that we:

  • Continue to invest billions of dollars annually in research and development in search of innovative therapies to address unmet medical needs. We’ve invested almost $20 billion in the last five years because we believe our expertise in drug discovery and development, human genomics and the complex process of biologics manufacturing will enable us to find new cures and treatments for society’s most serious and costly diseases. Our goal is to enable people to live longer, more productive and higher-quality lives, while reducing the cost of managing disease. By thoughtfully executing on our mission and strategy, we believe we will also earn an appropriate return for the many thousands of people who have committed their investment capital to Amgen.

  • Develop more affordable therapeutic choices in the form of high-quality and reliably-supplied biosimilars. We currently have a robust pipeline of biosimilar molecules, which target some of the most complex and important oncology and inflammation antibody biologics.

  • Price our medicines to reflect the value they provide for patients, payers and society. We are also transparent about how we determine that value, by making our data publicly available via congresses, peer-reviewed journals and our medical information team. Amgen has been – and will continue to be – transparent about the pricing components of its revenues, having for over a decade publicly disclosed the impact of rebates and discounts on revenues.

  • Partner with payers to share risk and accountability for health outcomes, and help ensure that patients can access the medicines they need without significant financial burden. We have been at the forefront of developing innovative contracting and partnerships designed to improve population health and patient access, as well as outcomes-based and risk-sharing approaches that directly link the price of our medicines to their performance. We will continue to explore new programs and partnerships.

  • Provide patient support and education programs and help patients in financial need access our medicines in many countries around the world. For those U.S. citizens unable to afford their prescribed medicines, Amgen contributes several hundred million dollars a year to free goods and other patient support programs.

  • Work with policymakers, patients and other stakeholders to establish a sustainable healthcare system with access to affordable care and where patients and their healthcare professionals are the primary decision makers.